Hitting HER2+ Breast Cancer With Both BarrelsHitting HER2+ Breast Cancer With Both Barrels

Dr. Lidia Schapira reports on a study showing an approach using targeted and hormonal therapies that can render chemotherapy unnecessary in a population of HER2+ breast cancer patients. Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Viewpoint Source Type: news